The therapeutic potential of purified cannabidiol

SE O'Sullivan, SS Jensen, GN Nikolajsen… - Journal of Cannabis …, 2023 - Springer
The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention,
with speculation that CBD can be useful in a wide range of conditions. Only one product, a …

Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review

RW de Camargo, LR de Novais Júnior… - Pharmacology …, 2022 - Elsevier
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, onset in early childhood
and associated with cognitive, social, behavioral, and sensory impairments. The …

[HTML][HTML] Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors

A Manduca, V Buzzelli, A Rava, A Feo… - Pharmacological …, 2024 - Elsevier
Abstract Cannabidiol (CBD), a non-psychotomimetic constituent of Cannabis sativa, has
been recently approved for epileptic syndromes often associated with Autism spectrum …

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease

V Trojan, L Landa, A Šulcová, J Slíva, R Hřib - Biomolecules, 2023 - mdpi.com
The use of cannabinoids (substances contained specifically in hemp plants) for therapeutic
purposes has received increased attention in recent years. Presently, attention is paid to two …

Cannabidiol and its potential evidence-based psychiatric benefits–a critical review

I Dammann, C Rohleder, FM Leweke - Pharmacopsychiatry, 2024 - thieme-connect.com
The endocannabinoid system shows promise as a novel target for treating psychiatric
conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in …

[PDF][PDF] 孤独症谱系障碍治疗的研究进展

叶洪佳, 王军 - 生命科学, 2023 - lifescience.sinh.ac.cn
孤独症谱系障碍又称自闭症, 是一种常见的神经发育障碍, 核心特征表现为社交互动的持续性
障碍, 以及行为, 兴趣和日常活动的刻板重复行为. 自闭症病因复杂, 迄今为止 …

Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a …

G Ferrera, E Ricci, A Vignoli, MN Savini, I Viganò… - Epilepsy & Behavior, 2023 - Elsevier
Seizure frequency in treatment-resistant epilepsies seems to be decreased by cannabidiol
(CBD), but contrasting data are available on its effect on sleep, behavior, and quality of life …

Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism

SH Shrader, N Mellen, J Cai, GN Barnes… - Frontiers in …, 2024 - frontiersin.org
Introduction The prevalence of Autism Spectrum Disorder (ASD) has drastically risen over
the last two decades and is currently estimated to affect 1 in 36 children in the US, according …

Parental Perceptions and Usage of Unlicensed Cannabidiol Products in Children With Anxiety and Neurodevelopmental Disorders

K Schwaller, Z Krauss, AMH Chen… - The Journal of …, 2023 - meridian.allenpress.com
OBJECTIVE Data evaluating the use of unlicensed cannabidiol (CBD) products for the
treatment of symptoms associated with anxiety and neurodevelopmental disorders in …

Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock‐in mice

X Li, M Yennawar, A Wiest, WT O'Brien… - European Journal of …, 2024 - Wiley Online Library
Abstract Cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD) is caused by a
loss‐of‐function mutation in CDKL5 gene, encoding a serine–threonine kinase highly …